Atomo NewsGet the app

Get the latest Science News and Discoveries

RECOVER-VITAL clinical trial finds no benefit of extended duration of PAXLOVID for Long COVID


None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Long Covid

Long Covid

Photo of Paxlovid

Paxlovid

Photo of benefit

benefit

Related news:

News photo

No demonstration of benefit with hydralazine plus isosorbide dinitrate in heart failure

News photo

COVID-19 awakens dormant viruses — and one is linked to long COVID

News photo

COVID can wake up a slew of dormant viruses inside you. Reactivation of typically harmless anelloviruses, in particular, seems to be linked with developing long COVID, study finds.

« A TAVI-first strategy was noninferior to a PCI-first strategy in patients with severe aortic stenosis and concomitant coronary artery disease
Low temperature graphene growth opens a route to sustainable resource recycling »